Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2001 Mar 27;987:4038-43. doi: 10.1073/pnas.061038798.
Show Gene links
Show Anatomy links
Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression.
Wang J
,
Silva JP
,
Gustafsson CM
,
Rustin P
,
Larsson NG
.
???displayArticle.abstract???
We have attempted to determine whether loss of mtDNA and respiratory chain function result in apoptosis in vivo. Apoptosis was studied in embryos with homozygous disruption of the mitochondrial transcription factor A gene (Tfam) and tissue-specific Tfam knockout animals with severe respiratory chain deficiency in the heart. We found massive apoptosis in Tfam knockout embryos at embryonic day (E) 9.5 and increased apoptosis in the heart of the tissue-specific Tfam knockouts. Furthermore, mtDNA-less (rho(0)) cell lines were susceptible to apoptosis induced by different stimuli in vitro. The data presented here provide in vivo evidence that respiratory chain deficiency predisposes cells to apoptosis, contrary to previous assumptions based on in vitro studies of cultured cells. These results suggest that increased apoptosis is a pathogenic event in human mtDNA mutation disorders. The finding that respiratory chain deficiency is associated with increased in vivo apoptosis may have important therapeutic implications for human disease. Respiratory chain deficiency and cell loss and/or apoptosis have been associated with neurodegeneration, heart failure, diabetes mellitus, and aging. Furthermore, chemotherapy and radiation treatment of cancer are intended to induce apoptosis in tumor cells. It would therefore be of interest to determine whether manipulation of respiratory chain function can be used to inhibit or enhance apoptosis in these conditions.
Arai,
Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.
1994, Pubmed
Arai,
Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.
1994,
Pubmed
Dey,
Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells.
2000,
Pubmed
Du,
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.
2000,
Pubmed
Enari,
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.
1998,
Pubmed
Green,
Mitochondria and apoptosis.
1998,
Pubmed
Hao,
Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background.
1999,
Pubmed
Jacobson,
Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA.
1993,
Pubmed
Jiang,
Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved.
1999,
Pubmed
Kanoh,
Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair.
1999,
Pubmed
King,
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.
1989,
Pubmed
Larsson,
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice.
1998,
Pubmed
Latta,
Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis.
2000,
Pubmed
Leist,
Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest.
1994,
Pubmed
Leist,
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.
1997,
Pubmed
Li,
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
1997,
Pubmed
Li,
Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis.
2000,
Pubmed
Liu,
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.
1997,
Pubmed
Luo,
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.
1998,
Pubmed
Marchetti,
Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA.
1996,
Pubmed
Melov,
Mitochondrial disease in superoxide dismutase 2 mutant mice.
1999,
Pubmed
Mirabella,
Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism.
2000,
Pubmed
Nagata,
Apoptosis by death factor.
1997,
Pubmed
Rustin,
Biochemical and molecular investigations in respiratory chain deficiencies.
1994,
Pubmed
Rötig,
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
1997,
Pubmed
Sakahira,
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis.
1998,
Pubmed
Silva,
Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes.
2000,
Pubmed
,
Xenbase
Susin,
Molecular characterization of mitochondrial apoptosis-inducing factor.
1999,
Pubmed
Wang,
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression.
1999,
Pubmed
,
Xenbase
Wankerl,
Calcium transport proteins in the nonfailing and failing heart: gene expression and function.
1995,
Pubmed
Ye,
Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis.
1999,
Pubmed